• Home
  • About Us
    • Overview
  • Research
    • Asbestos Voices: Defining Research Priorities
    • Biobank/Biomarkers
    • Bioinformatics/Systems Biology
    • Genomics Sequencing
    • Imaging: Human & Mouse
    • Mouse Models
    • Novel Therapies
    • Tumour Immunology
  • News and Resources
    • Patient and Family Information
    • Clinical Trials
    • Asbestos Review Program
    • NCARD Publications
    • News
  • Study With Us
    • Alumni
  • Contact Us
DONATE
  • Home
  • About Us
    • Overview
  • Research
    • Asbestos Voices: Defining Research Priorities
    • Biobank/Biomarkers
    • Bioinformatics/Systems Biology
    • Genomics Sequencing
    • Imaging: Human & Mouse
    • Mouse Models
    • Novel Therapies
    • Tumour Immunology
  • News and Resources
    • Patient and Family Information
    • Clinical Trials
    • Asbestos Review Program
    • NCARD Publications
    • News
  • Study With Us
    • Alumni
  • Contact Us

Newsletter July 2021

Newsletter
5 years ago
NCARD eNews Jul 2021

Newsletter December 2020

Newsletter
5 years ago
NCARD eNews Dec 2020

Neo-antigen specific T cell responses indicate the presence of metastases before imaging

Publications
7 years ago

Newsletter July 2019

Newsletter
7 years ago
Newsletter July 2019

Newsletter December 2018

Newsletter
7 years ago
Newsletter Dec 2018

Newsletter July 2018

Newsletter
8 years ago
Bruce Robinson NCARD

Bibliometric analysis of gaps in research on asbestos-related diseases: declining emphasis on public health over 26 years

Publications
8 years ago

Combination immune checkpoint blockade as an effective therapy for mesothelioma

Publications
8 years ago

Newsletter December 2017

Newsletter
8 years ago
NCARD newsletter December 2017

Newsletter June 2017

Newsletter
9 years ago
NCARD newsletter July 2017

Transient Treg depletion enhances therapeutic anti-cancer vaccination

Publications
9 years ago
National Centre for Asbestos Related Diseases

NCARD researchers are recognised as world leaders. We have an extensive collaborative network with leading researchers across the globe.

NCARD is part of the University of Western Australia (UWA) and Institute for Respiratory Health (IRH).

Latest News

Recent Posts

  • External study recognises WA leadership in pleural mesothelioma biomarker research April 10, 2026
  • Callum Flanagan awarded 2025 Douglas Peter Swift Scholarship January 28, 2026
  • NCARD researchers awarded 2025 Raine Priming Grants for cancer research January 15, 2026
  • NCARD at iMig 2025: Showcasing Leadership, Collaboration, and the Future of Mesothelioma Research December 17, 2025
Scientific Publications

NCARD researchers have published hundreds of peer-reviewed articles on mesothelioma and related research. Visit our Scientific Publications page to see papers from the last several years.

Subscribe

Keep in touch by subscribing to the NCARD newsletter.

Contacts
ncard-research@uwa.edu.au
(08) 6151 1078

QQ Block
QEII Medical Campus
6 Verdun Street
Nedlands
6009

Designed by Redhead Digital Marketing